Skip to content

Clinical trials

Phase 1/2 Lymphoma, Follicular trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lymphoma, Follicular Phase: Phase 1/2 Clear all

183 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20005
20012
20022
20034
20045
200510
20064
20075
20088
20095
20107
20115
20123
20136
20148
201511
201614
201712
20182
20198
202014
20216
20226
20238
20243
20251
20265

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed89
Terminated29
Recruiting21
Active, not recruiting20
Withdrawn13
Unknown status11

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Cancer Institute (NCI)10
Mayo Clinic8
Fred Hutchinson Cancer Center7
Hoffmann-La Roche6
M.D. Anderson Cancer Center6
Northwestern University6
City of Hope Medical Center5
Masonic Cancer Center, University of Minnesota4
Memorial Sloan Kettering Cancer Center4
BeiGene3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lymphoma, Follicular183
Lymphoma, Mantle-Cell112
Lymphoma, Large B-Cell, Diffuse105
Lymphoma, B-Cell, Marginal Zone91
Lymphoma, Non-Hodgkin91
Leukemia, Lymphocytic, Chronic, B-Cell89
Lymphoma69
Burkitt Lymphoma49
Precursor Cell Lymphoblastic Leukemia-Lymphoma45
Waldenstrom Macroglobulinemia44

Trials

Showing 51 to 75 of 183. Each trial links to its page on Pharma Observatory.

83 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.